EUVIMEDEUVIMED entdecken
Crossref

Epicardial Lead Performance Trends in Pediatric and Congenital Heart Disease

Brynn E Dechert iD, Vikram Sood, Martin J LaPage

World Journal for Pediatric and Congenital Heart Surgery · 2025

DOI: 10.1177/21501351241293722 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal for Pediatric and Congenital Heart Surgery, 2025. Verfasst von Brynn E Dechert und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Michigan, Ann Arbor, MI, USA. Hauptthemen laut MEDLINE: Heart Defects, Congenital, Pacemaker, Artificial, Pericardium, Electrodes, Implanted. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Epicardial pacing systems, rather than transvenous systems, are utilized in pediatric patients who are too small to undergo transvenous access and/or have complex congenital heart disease (CHD) anatomically precluding a transvenous system. Longitudinal performance studies indicate that epicardial leads have higher failure rates when compared with transvenous leads but there are limited data on lead measurement changes in the acute phase after implantation. The objective of this study was to assess epicardial lead performance in the acute postimplant period and at one-year follow-up.

Methods

This is a retrospective single center study of children and adult patients with CHD undergoing epicardial bipolar pacing lead and generator implantation between January 2012 and June 2022. We empirically selected 2 V as a critical lead threshold.

Results

There were 256 leads implanted in 127 patients (mean age 6.1 ± 9.8 years), including 201/256 (79%) leads in patients with CHD. At the time of implant, 47/256 leads (18%) had a lead threshold of ≥2 V. Of those, 42 of 47 (89%) had recorded threshold values on postoperative day 1 (POD1) and 37 of 42 (88%) had decreased to a more acceptable threshold that was 1000 ohms, presence of CHD, perioperative or acute postop status, and location of the lead (atrial vs ventricular) did not significantly impact the odds of having a persistently high threshold (≥2 V) on POD1.

Conclusion

Epicardial pacing lead thresholds generally improve in the immediate postop period and in our experience most leads with a high implant threshold improved to

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart Defects, CongenitalPacemaker, ArtificialPericardiumElectrodes, ImplantedCardiac Pacing, ArtificialHumansRetrospective StudiesChildFemaleMaleChild, PreschoolAdolescentAdultInfantFollow-Up StudiesYoung Adult

Stichwörter der Autor:innen

congenital heart diseasepacemakerpediatricthreshold

Autor:innen und Institutionen

  • Department of Pediatrics, University of Michigan, Ann Arbor, MI, USA.
  • Department of Cardiac Surgery, University of Michigan, Ann Arbor, MI, USA.

ORCID-Profile: Brynn E Dechert

Zitieren

APA

Dechert, B. E., Sood, V., & LaPage, M. J. (2025). Epicardial Lead Performance Trends in Pediatric and Congenital Heart Disease. World Journal for Pediatric and Congenital Heart Surgery. https://doi.org/10.1177/21501351241293722

Vancouver

Dechert BE, Sood V, LaPage MJ. Epicardial Lead Performance Trends in Pediatric and Congenital Heart Disease. World Journal for Pediatric and Congenital Heart Surgery. 2025. doi:10.1177/21501351241293722

BibTeX
@article{Dechert2025,
  author = {Dechert, Brynn E and Sood, Vikram and LaPage, Martin J},
  title = {Epicardial Lead Performance Trends in Pediatric and Congenital Heart Disease},
  journal = {World Journal for Pediatric and Congenital Heart Surgery},
  year = {2025},
  doi = {10.1177/21501351241293722}
}
Kostenlos starten →